Cizzle Biotechnology Holdings Plc (LON:CIZ)

LON:CIZ Income Statement

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Selling, General & Admin	0.73	0.88	0.98	0.96	0.85
Other Operating Expenses	0.02	1.39	0.79	-	3.11
Total Operating Expenses	0.75	2.27	1.76	0.96	3.96
Operating Income	-0.75	-2.19	-1.76	-0.96	-3.96
Pretax Income	-0.75	-2.19	-1.76	-0.96	-3.96
Provision for Income Taxes	-0.06	-0.02	-0.05	-0.05	-0.04
Net Income	-0.69	-2.17	-1.72	-0.91	-3.92
Net Income to Common	-0.69	-2.17	-1.72	-0.91	-3.92
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	396	387	356	291	161
Shares Outstanding (Diluted)	396	387	356	291	161
Shares Change (YoY)	2.30%	8.88%	22.15%	81.49%	-
EPS (Basic)	-0.00	-0.01	-0.01	-0.00	-0.02
EPS (Diluted)	-0.00	-0.01	-0.01	-0.00	-0.02
EPS Growth	-	-	-	-	-
Free Cash Flow	-0.5	-0.36	-0.64	-0.87	-1.01
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.01
EBITDA	-0.75	-2.19	-1.76	-0.96	-3.96
EBIT	-0.75	-2.19	-1.76	-0.96	-3.96
Effective Tax Rate	7.99%	0.96%	2.61%	5.30%	0.93%

Data Source: Fiscal.ai Last updated: Apr 30, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 26, 2026

Data Sources Report a data error